Viewing Protocol Section

Home

Stocks

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

eRecord

Main Search All Studies All Organizations Report Bug

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT06500702

Ignite Creation Date: 2024-07-17 @ 10:44 AM

Last Modification Date: 2024-10-26 @ 3:34 PM

Study NCT ID: NCT06500702

Protocol Section: NCT06500702

Start Identification Module Data

Expand Identification Module Data

Brief Title: A Study to Evaluate the Efficacy and Safety of Frexalimab SAR442970 or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Official Title: A Parallel-group Treatment Phase 2a Multicenter Randomized Double-blind Placebo-controlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab SAR442970 and Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis FSGS or Minimal Change Disease MCD

Acronym: RESULT

Organization: Sanofi

Organization Class: INDUSTRY

Organization Study ID: ACT18064

Secondary IDs

Secondary ID	Type	Domain	Link

2024-511775-15	REGISTRY	None	None
U1111-1301-2676	REGISTRY	None	None

Start Status Module Data

Status Verified Date: 2024-10

Overall Status: RECRUITING

Study First Submit Date:

Study First Submit QC Date:

Last Update Submit Date:

Status:

Start Sponsor Collaborators Module Data

Investigator:

Lead Sponsor: Sanofi

Lead Sponsor Class: INDUSTRY

Lead Sponsor: Sanofi

Start Oversight Module Data

Description Module:

Study Last Update Post Date Type(Status Module):

Attachment: Upload